Element Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.02 M
- Revenue Growth 13.79%
- Profit Growth -10.91%
- Ebitda -4.47%
- Net Worth 13.13%
- Total Assets 13.94%
About Element Pharmaceuticals
Element Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2012 and has a history of 12 years and five months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.02 M.
Ranjit Pharande, Sachin Kolhapure, Vishal Hingane, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100PN2012PTC144674
- Company No.
144674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Element Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjit Pharande  | Director | 01-Jul-2013 | Current |
| Sachin Kolhapure | Director | 01-Jul-2013 | Current |
| Vishal Hingane | Director | 01-Jul-2013 | Current |
| Anil Borse | Director | 01-Jul-2013 | Current |
Financial Performance of Element Pharmaceuticals.
Element Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.79% increase. The company also saw a substantial fall in profitability, with a 10.91% decrease in profit. The company's net worth Soared by an impressive increase of 13.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Element Pharmaceuticals?
In 2021, Element Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quadrant Lifesciences Private LimitedRanjit Pharande, Sachin Kolhapure and 2 more are mutual person
Charges (Loans)
₹1.02 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2023 | Hdfc Bank Limited | ₹1.02 M | Open |
How Many Employees Work at Element Pharmaceuticals?
Element Pharmaceuticals has a workforce of 39 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Element Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Element Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
